tirzepatide subcutaneous injection 15 mg at ₹ 6000/vial | Nagpur Mounjaro (tirzepatide): Uses, Side Effects,
Description
The Phase 2 data showed 24.2% average body weight reduction over 48 weeks at the 12mg dose
When should we consider adjusting the dose
Obesity Surgery , 33(2), 567580
Gasbjerg LS, Helsted MM, Hartmann B, Jensen MH, Gabe MBN, Sparre-Ulrich AH, Veedfald S, Stensen S, Lanng AR, Bergmann NC, et al
95% CI, 0.590.83
Adverse effect management requires awareness of centrally mediated symptoms
